ISTO Technologies recently received a Small Business Innovation Research grant from the National Institutes of Health.
Here are five facts:
1. The award grants funds of up to $1.2 million.
2. The funds will be used for pre-clinical research focusing on the application of the company's biosynthetic scaffold, InQu, to repair chondral defects.
3. The two-year study is being led by Anthony J. Ward, PhD, principal scientist at ISTO Technologies.
4. The study aims to pave the way for clinical studies to support commercial approval of InQu for cartilage repair.
5. ISTO is a privately held orthobiologics company focusing on spinal therapies and sports medicine.